Keyword Analysis & Research: tango therapeutics
Keyword Research: People who searched tango therapeutics also searched
Search Results related to tango therapeutics on Search Engine
-
Tango Therapeutics
https://www.tangotx.com/
WebRobust Pipeline. Bold Leadership. Passionate Team. We are leveraging the principle of synthetic lethality to develop medicines that take direct aim at specific tumors. Using an …
DA: 26 PA: 69 MOZ Rank: 73
-
Pipeline - Tango Therapeutics
https://www.tangotx.com/pipeline/
WebWe are leveraging the genetic principle of synthetic lethality and the power of our state-of-the-art CRISPR-based target discovery engine to discover and validate multiple novel …
DA: 56 PA: 53 MOZ Rank: 93
-
Investor Relations | Tango Therapeutics, Inc
https://ir.tangotx.com/
WebFeb 7, 2024 · Corporate Profile. Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop …
DA: 29 PA: 74 MOZ Rank: 22
-
Leadership - Tango Therapeutics
https://www.tangotx.com/leadership/
WebLeadership. We are leaders in drug discovery, cancer biology, functional genomics and translational medicine pursuing the bold goal of tackling the genetic complexity of cancer. We are focused on drivers of cancer not targeted by current drugs as we seek to address a large unmet need for people with cancer.
DA: 67 PA: 41 MOZ Rank: 77
-
Approach - Tango Therapeutics
https://www.tangotx.com/science/our-approach/
WebTango Therapeutics 201 Brookline Ave, Suite 901 Boston, MA 02215 Tel: +1-857-320-4900. Contact; Careers
DA: 78 PA: 74 MOZ Rank: 81
-
Tango Therapeutics Announces FDA Clearance of Investigational …
https://ir.tangotx.com/news-releases/news-release-details/tango-therapeutics-announces-fda-clearance-investigational-new-1
WebSep 06, 2023. PDF Version. BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that the U.S. Food and Drug Administration (FDA) has cleared the …
DA: 3 PA: 13 MOZ Rank: 67
-
Tango Therapeutics, Inc. (TNGX) - Yahoo Finance
https://finance.yahoo.com/quote/TNGX
WebTango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein...
DA: 3 PA: 83 MOZ Rank: 24
-
News Releases | Tango Therapeutics, Inc
https://ir.tangotx.com/news-events/news-releases
WebJan 03, 2024. Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG348 in Patients with BRCA1/2-Mutant and Other HRD+ Cancers.
DA: 10 PA: 99 MOZ Rank: 9
-
Tango Therapeutics | LinkedIn
https://www.linkedin.com/company/tango-therapeutics
WebTango Therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. Tango was...
DA: 33 PA: 39 MOZ Rank: 88
-
News Release Details - Tango Therapeutics, Inc
https://ir.tangotx.com/news-releases/news-release-details/tango-therapeutics-announces-fda-clearance-investigational-new
WebBOSTON, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application for …
DA: 30 PA: 62 MOZ Rank: 29